List of Tables
Table 1. Global Therapeutic Peptide APIs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Therapeutic Peptide APIs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Therapeutic Peptide APIs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Therapeutic Peptide APIs Sales (Tons) of Key Manufacturers (2021–2026)
Table 5. Global Therapeutic Peptide APIs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Therapeutic Peptide APIs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Therapeutic Peptide APIs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Therapeutic Peptide APIs Average Price (US$/kg) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Therapeutic Peptide APIs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Therapeutic Peptide APIs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Therapeutic Peptide APIs, Product Types and Applications
Table 12. Global Key Manufacturers of Therapeutic Peptide APIs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Therapeutic Peptide APIs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Therapeutic Peptide APIs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Therapeutic Peptide APIs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Therapeutic Peptide APIs Sales by Region (Tons), 2021–2026
Table 18. Global Therapeutic Peptide APIs Sales Market Share by Region (2021–2026)
Table 19. Global Therapeutic Peptide APIs Sales by Region (Tons), 2027–2032
Table 20. Global Therapeutic Peptide APIs Sales Market Share by Region (2027–2032)
Table 21. Global Therapeutic Peptide APIs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Therapeutic Peptide APIs Revenue Market Share by Region (2021–2026)
Table 23. Global Therapeutic Peptide APIs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Therapeutic Peptide APIs Revenue Market Share by Region (2027–2032)
Table 25. North America Therapeutic Peptide APIs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Therapeutic Peptide APIs Sales by Country (Tons), 2021–2026
Table 27. North America Therapeutic Peptide APIs Sales by Country (Tons), 2027–2032
Table 28. North America Therapeutic Peptide APIs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Therapeutic Peptide APIs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Therapeutic Peptide APIs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Therapeutic Peptide APIs Sales by Country (Tons), 2021–2026
Table 32. Europe Therapeutic Peptide APIs Sales by Country (Tons), 2027–2032
Table 33. Europe Therapeutic Peptide APIs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Therapeutic Peptide APIs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Therapeutic Peptide APIs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Therapeutic Peptide APIs Sales by Region (Tons), 2021–2026
Table 37. Asia Pacific Therapeutic Peptide APIs Sales by Region (Tons), 2027–2032
Table 38. Asia Pacific Therapeutic Peptide APIs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Therapeutic Peptide APIs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Therapeutic Peptide APIs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Therapeutic Peptide APIs Sales by Country (Tons), 2021–2026
Table 42. Latin America Therapeutic Peptide APIs Sales by Country (Tons), 2027–2032
Table 43. Latin America Therapeutic Peptide APIs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Therapeutic Peptide APIs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Therapeutic Peptide APIs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Therapeutic Peptide APIs Sales by Country (Tons), 2021–2026
Table 47. Middle East and Africa Therapeutic Peptide APIs Sales by Country (Tons), 2027–2032
Table 48. Middle East and Africa Therapeutic Peptide APIs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Therapeutic Peptide APIs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Therapeutic Peptide APIs Sales (Tons) by Type (2021–2026)
Table 51. Global Therapeutic Peptide APIs Sales (Tons) by Type (2027–2032)
Table 52. Global Therapeutic Peptide APIs Sales Market Share by Type (2021–2026)
Table 53. Global Therapeutic Peptide APIs Sales Market Share by Type (2027–2032)
Table 54. Global Therapeutic Peptide APIs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Therapeutic Peptide APIs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Therapeutic Peptide APIs Revenue Market Share by Type (2021–2026)
Table 57. Global Therapeutic Peptide APIs Revenue Market Share by Type (2027–2032)
Table 58. Global Therapeutic Peptide APIs Price (US$/kg) by Type (2021–2026)
Table 59. Global Therapeutic Peptide APIs Price (US$/kg) by Type (2027–2032)
Table 60. Global Therapeutic Peptide APIs Sales (Tons) by Application (2021–2026)
Table 61. Global Therapeutic Peptide APIs Sales (Tons) by Application (2027–2032)
Table 62. Global Therapeutic Peptide APIs Sales Market Share by Application (2021–2026)
Table 63. Global Therapeutic Peptide APIs Sales Market Share by Application (2027–2032)
Table 64. Global Therapeutic Peptide APIs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Therapeutic Peptide APIs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Therapeutic Peptide APIs Revenue Market Share by Application (2021–2026)
Table 67. Global Therapeutic Peptide APIs Revenue Market Share by Application (2027–2032)
Table 68. Global Therapeutic Peptide APIs Price (US$/kg) by Application (2021–2026)
Table 69. Global Therapeutic Peptide APIs Price (US$/kg) by Application (2027–2032)
Table 70. Bachem Company Information
Table 71. Bachem Description and Business Overview
Table 72. Bachem Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 73. Bachem Therapeutic Peptide APIs Product
Table 74. Bachem Recent Developments/Updates
Table 75. GenScript Company Information
Table 76. GenScript Description and Business Overview
Table 77. GenScript Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 78. GenScript Therapeutic Peptide APIs Product
Table 79. GenScript Recent Developments/Updates
Table 80. AmbioPharm Company Information
Table 81. AmbioPharm Description and Business Overview
Table 82. AmbioPharm Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 83. AmbioPharm Therapeutic Peptide APIs Product
Table 84. AmbioPharm Recent Developments/Updates
Table 85. Limitless Biotech Company Information
Table 86. Limitless Biotech Description and Business Overview
Table 87. Limitless Biotech Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 88. Limitless Biotech Therapeutic Peptide APIs Product
Table 89. Limitless Biotech Recent Developments/Updates
Table 90. CPC Scientific Company Information
Table 91. CPC Scientific Description and Business Overview
Table 92. CPC Scientific Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 93. CPC Scientific Therapeutic Peptide APIs Product
Table 94. CPC Scientific Recent Developments/Updates
Table 95. PolyPeptide Company Information
Table 96. PolyPeptide Description and Business Overview
Table 97. PolyPeptide Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 98. PolyPeptide Therapeutic Peptide APIs Product
Table 99. PolyPeptide Recent Developments/Updates
Table 100. CordenPharma Company Information
Table 101. CordenPharma Description and Business Overview
Table 102. CordenPharma Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 103. CordenPharma Therapeutic Peptide APIs Product
Table 104. CordenPharma Recent Developments/Updates
Table 105. Lonza Company Information
Table 106. Lonza Description and Business Overview
Table 107. Lonza Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 108. Lonza Therapeutic Peptide APIs Product
Table 109. Lonza Recent Developments/Updates
Table 110. Aspen API Company Information
Table 111. Aspen API Description and Business Overview
Table 112. Aspen API Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 113. Aspen API Therapeutic Peptide APIs Product
Table 114. Aspen API Recent Developments/Updates
Table 115. Syngene Company Information
Table 116. Syngene Description and Business Overview
Table 117. Syngene Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 118. Syngene Therapeutic Peptide APIs Product
Table 119. Syngene Recent Developments/Updates
Table 120. USV Peptides Company Information
Table 121. USV Peptides Description and Business Overview
Table 122. USV Peptides Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 123. USV Peptides Therapeutic Peptide APIs Product
Table 124. USV Peptides Recent Developments/Updates
Table 125. Bio Basic Company Information
Table 126. Bio Basic Description and Business Overview
Table 127. Bio Basic Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 128. Bio Basic Therapeutic Peptide APIs Product
Table 129. Bio Basic Recent Developments/Updates
Table 130. JPT Peptide Technologies Company Information
Table 131. JPT Peptide Technologies Description and Business Overview
Table 132. JPT Peptide Technologies Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 133. JPT Peptide Technologies Therapeutic Peptide APIs Product
Table 134. JPT Peptide Technologies Recent Developments/Updates
Table 135. ScinoPharm Company Information
Table 136. ScinoPharm Description and Business Overview
Table 137. ScinoPharm Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 138. ScinoPharm Therapeutic Peptide APIs Product
Table 139. ScinoPharm Recent Developments/Updates
Table 140. Piramal Pharma Company Information
Table 141. Piramal Pharma Description and Business Overview
Table 142. Piramal Pharma Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 143. Piramal Pharma Therapeutic Peptide APIs Product
Table 144. Piramal Pharma Recent Developments/Updates
Table 145. Jiangsu Sinopep-Allsino Biopharmaceutical Company Information
Table 146. Jiangsu Sinopep-Allsino Biopharmaceutical Description and Business Overview
Table 147. Jiangsu Sinopep-Allsino Biopharmaceutical Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 148. Jiangsu Sinopep-Allsino Biopharmaceutical Therapeutic Peptide APIs Product
Table 149. Jiangsu Sinopep-Allsino Biopharmaceutical Recent Developments/Updates
Table 150. Cheng Du Sheng Nuo Biotec Company Information
Table 151. Cheng Du Sheng Nuo Biotec Description and Business Overview
Table 152. Cheng Du Sheng Nuo Biotec Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 153. Cheng Du Sheng Nuo Biotec Therapeutic Peptide APIs Product
Table 154. Cheng Du Sheng Nuo Biotec Recent Developments/Updates
Table 155. Hybio Pharmaceutical Company Information
Table 156. Hybio Pharmaceutical Description and Business Overview
Table 157. Hybio Pharmaceutical Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 158. Hybio Pharmaceutical Therapeutic Peptide APIs Product
Table 159. Hybio Pharmaceutical Recent Developments/Updates
Table 160. Hainan Shuangcheng Pharmaceuticals Company Information
Table 161. Hainan Shuangcheng Pharmaceuticals Description and Business Overview
Table 162. Hainan Shuangcheng Pharmaceuticals Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 163. Hainan Shuangcheng Pharmaceuticals Therapeutic Peptide APIs Product
Table 164. Hainan Shuangcheng Pharmaceuticals Recent Developments/Updates
Table 165. Guangdong Jianyuan Pharmaceutical Company Information
Table 166. Guangdong Jianyuan Pharmaceutical Description and Business Overview
Table 167. Guangdong Jianyuan Pharmaceutical Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 168. Guangdong Jianyuan Pharmaceutical Therapeutic Peptide APIs Product
Table 169. Guangdong Jianyuan Pharmaceutical Recent Developments/Updates
Table 170. Zhejiang Peptites Biotech Company Information
Table 171. Zhejiang Peptites Biotech Description and Business Overview
Table 172. Zhejiang Peptites Biotech Therapeutic Peptide APIs Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
Table 173. Zhejiang Peptites Biotech Therapeutic Peptide APIs Product
Table 174. Zhejiang Peptites Biotech Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Therapeutic Peptide APIs Distributors List
Table 178. Therapeutic Peptide APIs Customers List
Table 179. Therapeutic Peptide APIs Market Trends
Table 180. Therapeutic Peptide APIs Market Drivers
Table 181. Therapeutic Peptide APIs Market Challenges
Table 182. Therapeutic Peptide APIs Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
Table 186. Authors List of This Report
List of Figures
Figure 1. Product Picture of Therapeutic Peptide APIs
Figure 2. Global Therapeutic Peptide APIs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Therapeutic Peptide APIs Market Share by Type: 2025 & 2032
Figure 4. Bioactive Peptides Product Picture
Figure 5. Synthetic Peptides Product Picture
Figure 6. Global Therapeutic Peptide APIs Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Therapeutic Peptide APIs Market Share by Application: 2025 & 2032
Figure 8. Pharmaceuticals
Figure 9. Scientific Research
Figure 10. Other
Figure 11. Global Therapeutic Peptide APIs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Therapeutic Peptide APIs Market Size (US$ Million), 2021–2032
Figure 13. Global Therapeutic Peptide APIs Sales (Tons), 2021–2032
Figure 14. Global Therapeutic Peptide APIs Average Price (US$/kg), 2021–2032
Figure 15. Therapeutic Peptide APIs Report Years Considered
Figure 16. Therapeutic Peptide APIs Sales Share by Manufacturers in 2025
Figure 17. Global Therapeutic Peptide APIs Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Therapeutic Peptide APIs Players: Market Share by Revenue in Therapeutic Peptide APIs in 2025
Figure 19. Therapeutic Peptide APIs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Therapeutic Peptide APIs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Therapeutic Peptide APIs Sales Market Share by Country (2021–2032)
Figure 22. North America Therapeutic Peptide APIs Revenue Market Share by Country (2021–2032)
Figure 23. United States Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Therapeutic Peptide APIs Sales Market Share by Country (2021–2032)
Figure 26. Europe Therapeutic Peptide APIs Revenue Market Share by Country (2021–2032)
Figure 27. Germany Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Therapeutic Peptide APIs Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Therapeutic Peptide APIs Revenue Market Share by Region (2021–2032)
Figure 34. China Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Therapeutic Peptide APIs Sales Market Share by Country (2021–2032)
Figure 42. Latin America Therapeutic Peptide APIs Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Therapeutic Peptide APIs Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Therapeutic Peptide APIs Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Therapeutic Peptide APIs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Therapeutic Peptide APIs by Type (2021–2032)
Figure 53. Global Revenue Market Share of Therapeutic Peptide APIs by Type (2021–2032)
Figure 54. Global Therapeutic Peptide APIs Price (US$/kg) by Type (2021–2032)
Figure 55. Global Sales Market Share of Therapeutic Peptide APIs by Application (2021–2032)
Figure 56. Global Revenue Market Share of Therapeutic Peptide APIs by Application (2021–2032)
Figure 57. Global Therapeutic Peptide APIs Price (US$/kg) by Application (2021–2032)
Figure 58. Therapeutic Peptide APIs Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
